Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

A recent clinical trial highlights how a high-fiber plant-based diet can improve health markers and potentially delay the ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

Conquer Cancer®, the ASCO Foundation, presented the 2025 Young Investigator Awards (YIAs) funded by Vaniam Group™ and Women ...

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online in ...

Music therapy appeared as effective as first-line cognitive behavioral therapy for reduction of anxiety among cancer ...